Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role and Mechanism of Adenosine A2A Receptor-Mediated Neuroinflammation in the Alleviation of Post-Stroke Sleep Disorders by Remote Ischemic Conditioning

NCT07874594 is registered in ClinicalTrials.gov with Sichuan Academy of Medical Sciences as lead sponsor.

NCT NCT07874594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07874594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role and Mechanism of Adenosine A2A Receptor-Mediated Neuroinflammation in the Alleviation of Post-Stroke Sleep Disorders by Remote Ischemic Conditioning
Lead sponsor
Sichuan Academy of Medical Sciences
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2026
Completion date
December 31, 2029
Enrollment
136 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, ischemic stroke, sleep wake disorders